National Institute of Allergy and Infectious Diseases
  Advanced Search
Help | Site Index | Contact Us
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID
NIAID > Labs & Scientific Resources > Resources for Researchers > DMID Services for Researchers > In Vitro Antiviral Screening Program

Resources for Researchers
 DMID Clinical Research Policies
 Rabbit Immunology
 HIV/AIDS Specimen Repository
 DAIDS Clinical Research Policies
 Clinical Research Toolkit
 CFAR
 DMID Services for Researchers

Services for Researchers

In Vitro Antiviral Screening Program 

Prioritization and Approval Process

Materials for testing are selected and prioritized by relevant program officers from the Division of Microbiology and Infectious Diseases (DMID). Submitted compounds will be evaluated based on criteria such as structural novelty and drug-like characteristics as well as the rationale for submission, program priorities, and budgeted capacities in the antiviral screens requested. Final decisions are communicated to the submitter by the NIAID Project Officer.

 

Contact Info

Christopher Tseng
DMID Program Officer
E-mail: ctseng@niaid.nih.gov




 
E-mail Icon E-mail this page
Print Icon Print this page

Contact Info

Christopher Tseng
DMID Program Officer
E-mail: ctseng@niaid.nih.gov




 
Home | Help | Site Index | Accessibility | Privacy Policy | Disclaimer | Links & Policies | FOIA | Contact Us Last Updated July 2, 2008
National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health National Institutes of Health (NIH) Department of Health and Human Services Department of Health and Human Services (HHS) USA Gov